首页 | 本学科首页   官方微博 | 高级检索  
     

新型冠状病毒肺炎患者并发心肌损伤的实验室及临床相关研究
引用本文:郑雨桐,闫美田,王兰,栾亮,刘静,田笑,万楠. 新型冠状病毒肺炎患者并发心肌损伤的实验室及临床相关研究[J]. 现代检验医学杂志, 2021, 0(1): 85-91. DOI: 10.3969/j.issn.1671-7414.2021.01.022
作者姓名:郑雨桐  闫美田  王兰  栾亮  刘静  田笑  万楠
作者单位:(1.大连医科大学,辽宁大连 116044;2.北部战区总医院检验科,沈阳 110016)
基金项目:辽宁省自然科学基金(2019-ZD-1027);泰康同济新型冠状病毒专项基金(Tktjky2020069)。
摘    要:目的 回顾性分析新型冠状病毒肺炎(COVID-19)并发心肌损伤的临床特点及独立危险性因素,探讨病毒直接损伤心肌组织的可能性.方法 选取2020年2月13日~3月30日收治于泰康同济(武汉)医院确诊为COVID-19的患者381例.通过超敏肌钙蛋白T水平将其分为心肌损伤组及非心肌损伤组,并对比两组患者的临床统计资料及实...

关 键 词:新型冠状病毒肺炎  心肌损伤  超敏肌钙蛋白T  肌红蛋白  肌酸激酶同工酶MB  独立危险因素

Laboratory and Clinical Study on COVID-19 Patients with Myocardial Injury
ZHENG Yu-tong,YAN Mei-tian,WANG Lan,LUAN Liang,LIU Jing,TIAN Xiao,WAN Nan. Laboratory and Clinical Study on COVID-19 Patients with Myocardial Injury[J]. Journal of Modern Laboratory Medicine, 2021, 0(1): 85-91. DOI: 10.3969/j.issn.1671-7414.2021.01.022
Authors:ZHENG Yu-tong  YAN Mei-tian  WANG Lan  LUAN Liang  LIU Jing  TIAN Xiao  WAN Nan
Affiliation:(1.Dalian Medical University,Liaoning Dalian 116044,China;2.Department of Laboratory Medicine, General Hospital of Northern Theater Command,Shenyang 110016,China)
Abstract:Objective The clinical characteristics and independent risk factors of COVID-19 with myocardial injury were analyzed retrospectively,and the possibility of direct injury of myocardial tissue by virus was discussed.Methods A total of 381 patients with COVID-19 were admitted to Taikang Tongji(Wuhan)Hospital from February 13,2020 to March 30,2020.According to the level of hypersensitive troponin T,they were divided into myocardial injury group and non-myocardial injury group,and the basic clinical data of the two groups were compared to analyze the risk factors of myocardial injury.The possibility of direct myocardial injury caused by virus was understood by analyzing the abnormalities of different myocardial injury markers.Results Compared with the nonmyocardial injury group,the myocardial injury group was older(t=10.522,P=0.000),and more people were≥60 years old and complicated with underlying diseases(χ^2=46.559,P=0.000).In terms of clinical classification,there were mainly severe patients in the myocardial injury group and ordinary patients in the non-myocardial injury group,accounting for 53.38%and 72.98%,respectively.The abnormal degree of all kinds of laboratory indexes in the myocardial injury group was higher than that in the myocardial injury group(t=-11.571~4.881,χ^2=19.551585~186.858,U=-10.729~16.120,P=0.000).Chronic heart disease,D-Dimer≥500 ng/ml and procalcitonin≥0.05 ng/ml were independent risk factors for myocardial injury in COVID-19 patients(P<0.05).The proportion of abnormal myocardial injury markers of HSTNT,MYO and CK-MB was 34.91%,11.02%and 5.25%,respectively.The abnormal situation of myocardial injury markers in critical patients was more prominent,and most of them were patients with underlying diseases.The patients with abnormal myocardial injury markers were stratified according to the course of disease on admission.The number of abnormal HSTNT reached the peak at 41~60 days,while the number of abnormal MYO and CK-MB showed a downward trend as a whole.Conclusion SARS-CoV-2 is less likely to attack myocardial tissue directly.However,COVID-19 patients with myocardial injury are mainly elderly men over 60 years old,often complicated with hypertension,chronic cardiac,cerebrovascular and pulmonary diseases.At the same time,chronic heart disease,D-dimer and abnormal increase of procalcitonin are independent risk factors for myocardial injury,which can effectively evaluate the possibility of myocardial injury in patients with COVID-19 and take preventive protective treatment for heart,lung and other important organs,so as to effectively reduce mortality.
Keywords:COVID-19  myocardial injury  HSTNT  MYO  CK-MB  independent risk factors
本文献已被 维普 等数据库收录!
点击此处可从《现代检验医学杂志》浏览原始摘要信息
点击此处可从《现代检验医学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号